Methotrexate, Apremilast Show Similar Efficiency Outcomes in Head-to-Head PsA Study
Both drugs were well tolerated and without any serious adverse events.
Joydeep Samanta Research In Chandigarh Health Assessment Questionnaire Rheumatology International American College Of Rheumatology Institute Of Medical Education
Source: hcplive.com